Recognify Life Sciences, a company Atai Life Sciences is a strategic investor in, said its trial for a cognitive decline treatment missed its primary endpoint. Atai shares fell 13% to $3.08 in ...

Italian oil major Eni raised some 2025 growth projections and said it would buy back up to roughly $1.76 billion of shares over the year despite commodity and currency headwinds. Write to Rob Curran ...

Meta, Amazon and Microsoft lead an earnings wave, along with a Fed meeting and Trump tariff deadline. Tesla robotaxi may ...

Stocks rose Wednesday after President Donald Trump announced the U.S. had reached a trade deal with Japan, lifting hope for ...

Investors are benefiting as the FTSE 100 hits record highs - here are the best performing shares and funds so far this year ...

US stock market continued its winning streak as the S&P 500 and Nasdaq Composite reached new record highs, driven by strong ...

Nuclear power is having its moment again. After decades in the wilderness, small modular reactors (SMRs) are emerging as a potentially transformative technology, backed by close to $1 billion in new U ...

At the center of this renaissance sits NuScale Power (SMR) - the only company with a U.S.-approved SMR design. Its stock has become a proxy for investors betting on the nuclear future - and judging by ...

As per provisional closing data, the barometer index, the S&P BSE Sensex, tanked 721.08 points or 0.88% to 81,463.09. The Nifty 50 index declined 225.10 points or 0.90% to 24,837. In two consecutive ...

Explore how the economy faces slowdown while still showing signs of resilient growth and strong consumer spending.

Dow's 17% plunge and 50% dividend cut reflect deep cyclical challenges, weak margins, and heavy debt. Click here to find out ...